Showing results (2141-2150 of 8,157) with videos related to

Sort By:
Pageof 816
Haematologica|September 2, 2017
Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitorTiziana Vaisitti, Federica Gaudino, Samedy Ouk, et al.
Haematologica|September 2, 2017
CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trialYasuhiro Oki, Kevin R Kelly, Ian Flinn, et al.
Haematologica|July 29, 2017
Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemiaBenjamin Kobitzsch, Nicola Gökbuget, Stefan Schwartz, et al.
Haematologica|July 29, 2017
Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphomaLaurent Jallades, Lucile Baseggio, Pierre Sujobert, et al.
Haematologica|July 9, 2016
A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patientsHendrika Hazendonk, Karin Fijnvandraat, Janske Lock, et al.
Haematologica|April 23, 2016
Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trialSrdan Verstovsek, Alessandro M Vannucchi, Martin Griesshammer, et al.
Haematologica|May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignanciesNathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
Haematologica|December 5, 2015
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myelomaThomas Dejoie, Michel Attal, Philippe Moreau, et al.
Haematologica|December 5, 2015
von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIIINicoletta Sorvillo, Robin B Hartholt, Esther Bloem, et al.
Haematologica|December 5, 2015
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trialChristophe Willekens, Odile Blanchet, Aline Renneville, et al.
Pageof 816